News and updates

The guidance sets out our revised approach to assessing concerns when they are first received.

Children born to women who take valproate during pregnancy are at significant risk of birth defects and persistent developmental disorders. As such, it is vital that women and girls are dispensed valproate safely. The GPhC is reminding all pharmacy...

The PSA has found that the GPhC met 15 out of 18 of its Standards of Good Regulation during 2021/22.

The GPhC in conjunction with seven other healthcare professional regulators has published its annual report on whistleblowing disclosures.